Is Kinesio Taping Treatment Effective in Children With Cerebral Palsy?

Investıgatıng the Effect of Kinesiotaping on Hand Functions in Children With Cerebral Palsy

Cerebral palsy (CP) is defined as a non-progressive lesion of the immature brain. Children with CP may present with a variety of motor impairments.

The impaired upper limb function of children with cerebral palsy (CP) limits and restricts participation in activities of daily living.

Kinesio Taping (KT) is commonly used in sport injuries, in neurology and oncology patients following the surgical protocols, and for pediatric rehabilitation to reduce pain, facilitate or inhibit muscle activity, prevent injuries, reposition joints, aid the lymphatic system, support postural alignment, and improve proprioception. Kinesiotaping is a treatment that has not been studied much and can be applied in cerebral palsy. The tapes were grouped as elastic and rigid. In fact, there has been a few studies that investigates the effect of upper extremity elastic kinesiotaping. High methodological studies about its efficacy in this population are rare.

Study Overview

• Status: Unknown
• Conditions: Cerebral Palsy
• Intervention / Treatment: Other: kinesiotaping

Detailed Description

34 Children with cerebral palsy aged between 6-18 applied to Dokuz Eylül Üniversity Medical School Hospital Physical Medicine ve Rehabilitation Department will be included the study. Patients have diagnosed as CP with the subgroup of diplegic, hemiplegic, tetraplegic and mixt. The upper extremity side will be chosen as the affected side for the hemiplegic CP's and for diplegic, tetraplegic CP's the side of upper extremity which children have been used to but have obstacles in daily life. The chosen upper extremity side will be taped with the functional correction technique on the dorsum of the hand and forearm by clinician. Patients will be taped at least 2-3 hours a day every day and they will be also recomended dealing with the grasping and releasing activities in daily living at about 2-3 hours a day. In a way that every patient has to be the control of themselves, 1 week before kinesiotaping, immediately after kinesiotaping and 1 week after the period of kinesiotaping patients will be evaluated with box and block test, nine hole peg test, modified house clasification score and the active/passive wrist dorsiflexion range of motion. The investigator will also note the gross motor function clasification system level, dominant hand side and affected side, for chosen upper extremity side's zancolli clasification, modified aschwort scale of wrist and hand fingers, manual ability clasification system level for every patient.

• Study Type: Interventional
• Enrollment (Anticipated): 34
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Zeynep Tokel; Phone Number: +905068535386; Email: zeyneptkl343@gmail.com

Study Locations

• Turkey
  • İ̇zmi̇r, Turkey, 35340
    • Recruiting
    • Dokuz Eylul University
    • Contact: Zeynep Tokel, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 6 years to 18 years (Child, Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Age between 6-18
2. Following up with diagnose of hemiplegic/diplegic/tetraplegic CP patients with current imaginig findings
3. Patient with stable clinical status
4. Stage ≤2 patients depended on the modified ascwort scale
5. Patients who are eligible to participate the study tests with suitable cognitive state
6. Patients who agreed to participate the study.

Exclusion Criteria:

1. Stage >2 patients depended on the modified ascwort scale
2. Botilinum toxin intervention to the upper extremity in the last 6 months.
3. Patients who undergo upper extremity surgery.
4. Patients who have contraindication for kinesiotaping (Wide and severe skin injury, open wounds at risk of infection , allergic reactions)
5. Patients with intense sensory and motor loss in the banding area
6. Patients classified in stage IIB and above according to Zancolli stage

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: kinesiotaping group(before/after); Hemiplegic CP:Kinesiotaping on the affected side; Diplegic, tetraplegic CP: side of upper extremity which children have been used to but have obstacles in daily life; intervention Duration: For 1 week at least 2-3 hours a day, renewing if it's necessary.; Note:Patients will be also recomended dealing with the grasping and releasing activities in daily living at about 2-3 hours a day.; Evaluation: In a way that every patient has to be the control of themselves, 1 week before kinesiotaping, immediately after kinesiotaping and 1 week after the period of kinesiotaping, patients will be evaluated with box and block test, nine hole peg test, modified house clasification and the active/passive wrist dorsiflexion range of motion

Other: kinesiotaping; The participants will receive kinesiotaping treatment on the affected side for the hemiplegic CP's and for diplegic, tetraplegic CP's the side of upper extremity which children have been used to but have obstacles in daily life for 1 week at least 2-3 hours a day, renewing if it's necessary. The participants will be also recomended dealing with the grasping and releasing activities in daily living at about 2-3 hours a day. In a way that every patient has to be the control of themselves, 1 week before kinesiotaping, immediately after kinesiotaping and 1 week after the period of kinesiotaping, patients will be evaluated with box and block test, nine hole peg test, modified house clasification and the active/passive wrist dorsiflexion range of motion

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Box and block test	With the stopwatch, it is recorded how many small cubes are transferred to the other side of the box within 60 seconds.	1 week before kinesiotaping and 1 week after the period of kinesiotaping (change form baseline will be evaluated)
Nine hole peg test	A wooden box with nine holes is placed in front of the patient and held in seconds with the stopwatch. Insersion and extraction time of pegs in second are noted.	1 week before kinesiotaping and 1 week after the period of kinesiotaping (change form baseline will be evaluated)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Modified house clasification score	The score obtained from the Modified House Classification is calculated by recording the patient's capabilities among the listed 32 activities	1 week before kinesiotaping and 1 week after the period of kinesiotaping (change form baseline will be evaluated)
Active/passive wrist dorsiflexion range of motion	With goniometer active/passive wrist dorsiflexion range of motion will be measured.	1 week before kinesiotaping and 1 week after the period of kinesiotaping (change form baseline will be evaluated)

Collaborators and Investigators

• Sponsor: Dokuz Eylul University
• Investigators: Principal Investigator: Zeynep Tokel, MD, Dokuz Eylul University

Study record dates

Study Major Dates

• Study Start (Actual): April 15, 2018
• Primary Completion (Anticipated): March 10, 2019
• Study Completion (Anticipated): March 10, 2019

Study Registration Dates

• First Submitted: January 23, 2019
• First Submitted That Met QC Criteria: January 25, 2019
• First Posted (Actual): January 28, 2019

Study Record Updates

• Last Update Posted (Actual): January 29, 2019
• Last Update Submitted That Met QC Criteria: January 25, 2019
• Last Verified: January 1, 2019

More Information

Terms related to this study

• Keywords: cerebral palsy; upper extremity kinesiotaping; modified house
• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations; Brain Damage, Chronic; Cerebral Palsy; Paralysis
• Other Study ID Numbers: DorkuzEUZTOKEL

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No